Prognostic indicators, measured at diagnosis, are important in breast cancer. They help clinicians select optimal treatment, provide rational bases for stratification of treatment trials and assist analysis of response to treatment. Univariate statistical survival curves have identified many such indicators. However, they do not explain why some patients, classified as favoured by one or other factor(s), experience early treatment failure, nor why a substantial number with unfavourable signs remain recurrence-free many years later. This study was undertaken to identify independent prognostic factors with the use of multivariate regression. A Cox proportional hazards model of disease-specific survival was based on 1184 primary breast cancer...
Histopathological and immunohistochemical findings on tissue microarrays, overall survival (OS), dis...
Histopathological and immunohistochemical findings on tissue microarrays, overall survival (OS), dis...
Histopathological and immunohistochemical findings on tissue microarrays, overall survival (OS), dis...
Prognostic indicators, measured at diagnosis, are important in breast cancer. They help clinicians s...
Abstract- Background: Prognostic factors of breast cancer not only act as a guide to overall prognos...
Purpose/Objective(s): The American Joint Committee on Cancer(AJCC) anatomic stage groups have arguab...
In 1990, 215 patients with operable breast cancer were entered into a prospective study of the progn...
There is an increasing recognition that breast cancer can be heterogeneous and composed of a variety...
In 1990, 215 patients with operable breast cancer were entered into a prospective study of the progn...
Breast cancer prognosis has improved greatly in recent years. Consequently, a thorough search for se...
Breast cancer prognosis has improved greatly in recent years. Consequently, a thorough search for se...
7Purpose: Prediction algorithms estimating survival rates for breast cancer (BC) based upon risk fac...
Summary In breast cancer patients. prognostic information required to plan post-surgical therapy is ...
The purpose of this study is to analyze the survival rate of patients with metastatic breast cancer ...
Aims Multigene assay is recommended currently for prognostic stratification of the clinically indet...
Histopathological and immunohistochemical findings on tissue microarrays, overall survival (OS), dis...
Histopathological and immunohistochemical findings on tissue microarrays, overall survival (OS), dis...
Histopathological and immunohistochemical findings on tissue microarrays, overall survival (OS), dis...
Prognostic indicators, measured at diagnosis, are important in breast cancer. They help clinicians s...
Abstract- Background: Prognostic factors of breast cancer not only act as a guide to overall prognos...
Purpose/Objective(s): The American Joint Committee on Cancer(AJCC) anatomic stage groups have arguab...
In 1990, 215 patients with operable breast cancer were entered into a prospective study of the progn...
There is an increasing recognition that breast cancer can be heterogeneous and composed of a variety...
In 1990, 215 patients with operable breast cancer were entered into a prospective study of the progn...
Breast cancer prognosis has improved greatly in recent years. Consequently, a thorough search for se...
Breast cancer prognosis has improved greatly in recent years. Consequently, a thorough search for se...
7Purpose: Prediction algorithms estimating survival rates for breast cancer (BC) based upon risk fac...
Summary In breast cancer patients. prognostic information required to plan post-surgical therapy is ...
The purpose of this study is to analyze the survival rate of patients with metastatic breast cancer ...
Aims Multigene assay is recommended currently for prognostic stratification of the clinically indet...
Histopathological and immunohistochemical findings on tissue microarrays, overall survival (OS), dis...
Histopathological and immunohistochemical findings on tissue microarrays, overall survival (OS), dis...
Histopathological and immunohistochemical findings on tissue microarrays, overall survival (OS), dis...